Trials / Completed
CompletedNCT05029219
Virtual Reality Intervention Procedure Simulator
A Prospective Randomized Controlled Study for the Efficacy of Virtual Reality Intervention Procedure Simulator on the Training of Pain Procedures
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Gangnam Severance Hospital · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to prove the effectiveness of the virtual reality program in educating lumbar transforaminal epidural blocks to novice doctors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Arm I (Virtual reality group) | In the preparatory session, the participant is given a survey. It is about demographic information such as gender, age, and age, as well as prior experience with the procedure. The primary test is performed with a fluoroscopy guided lumbar transforaminal epidural block with a human-shaped phantom. After that, the test group and the control group receive the same audiovisual education for about 5 minutes. The test group receives about 60 minutes of training using a virtual reality program. |
| DEVICE | Arm II (Self study group) | In the preparatory session, the participant is given a survey. It is about demographic information such as gender, age, and age, as well as prior experience with the procedure. The primary test is performed with a fluoroscopy guided lumbar transforaminal epidural block with a human-shaped phantom. After that, the test group and the control group receive the same audiovisual education for about 5 minutes. The control group have provided with video materials and books provided during audiovisual education and have given time for self-study for 60 minutes. Subsequently, a second test is performed with a fluroscopy-guided lumbar transforaminal epidural block with a human-shaped phantom. |
Timeline
- Start date
- 2021-08-31
- Primary completion
- 2021-11-30
- Completion
- 2021-11-30
- First posted
- 2021-08-31
- Last updated
- 2022-01-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05029219. Inclusion in this directory is not an endorsement.